Septic hip abscess due to Fusobacterium nucleatum and Actinomyces turicensis in an immunocompetent SARS-CoV-2 positive patient.

Abstract

A 42-year-old man was referred to the Department of Orthopedic Surgery with pain over his right greater trochanter and signs of systemic infection. CT showed an enhanced mass in his gluteus maximus as well as gas in the biceps femoris over the underlying hip joint. Tissue biopsy yielded Fusobacterium nucleatum and Actinomyces turicensis. The patient was successfully treated for 6 weeks with amoxicillin/clavulanic acid 875mg/125mg and metronidazole 500mg.

• Authors: A Nia, A Ungersboeck, M Uffmann, D Leaper, O Assadian
• Journal: Anaerobe (Anaerobe) Vol. 71 Pg. 102420 (Oct 2021) ISSN: 1095-8274 [Electronic] England
• PMID: 34314865 (Publication Type: Case Reports)
• Copyright: Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Chemical References

• Anti-Bacterial Agents

Topics

• Abscess (drug therapy, microbiology)
• Actinomycetaceae (drug effects, genetics, isolation & purification)
• Actinomycetales Infections (drug therapy, microbiology)
• Adult
• Anti-Bacterial Agents (therapeutic use)
• Bacteremia (microbiology)
• COVID-19 (immunology, virology)
• Fusobacterium Infections (drug therapy, microbiology)
• Fusobacterium nucleatum (drug effects, genetics, isolation & purification)
• Hip (microbiology)
• Humans
• Immunocompromised Host
• Male
• SARS-CoV-2 (genetics, isolation & purification)